Bgm Group Ltd (BGM) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Bgm Group Ltd  (BGM)

Select the Financial Report: Select the Period:


Description of Bgm Group Ltd's Business Segments
The company operates through three segments as defined by ASC 280: Diversified Pharmaceutical and Allied Products, AI Solutions, and Insurance Business. All segments primarily manufacture and distribute products within China, with no revenue generated from international markets. The company uses the management approach to identify reportable segments based on internal organization and reporting to the chief operating decision maker. Financial data for the years ended September 30, 2025, 2024, and 2023 include revenue, cost of revenue, gross profit, depreciation and amortization, and capital expenditures for each segment. The AI Solutions and Insurance Business segments were acquired on November 1, 2024, through share subscription agreements with Ahanzhai Development Co., Ltd and LX Management Company Limited.

Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.



Annual Report on Bgm Group Ltd Divisions, Sales by Country

 
Oxytetracycline Licorice products and TCMD   Oxytetracycline Licorice products and TCMD Segment contribution to total sales 91.07 % of total Revenue
Fertilizer   Fertilizer Segment contribution to total sales 3.76 % of total Revenue
Heparin products and Sausage casing   Heparin products and Sausage casing Segment contribution to total sales 9.25 % of total Revenue


Twelve months ended 2024
BGM s Annual Revenue by Geography and Business Segments Sales
(in millions $)		 %
(of total Sales)
Oxytetracycline Licorice products and TCMD 21.96 91.07 %
Fertilizer 0.91 3.76 %
Heparin products and Sausage casing 2.23 9.25 %
Total 24.11 100 %


Twelve months ended 2024
BGM s Annual Income by Country and Business Segments Income
(in millions $)		 %
(Profit Margin)
Total -1.52 -

Twelve months ended 2024
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Oxytetracycline Licorice products and TCMD -24.67 % -
Fertilizer -54.71 % -
Heparin products and Sausage casing -86.29 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.